Fears GPs will resist giving drug injectors new antivirals

HEALTHCARE professionals will need to suspend their prejudices towards hepatitis C patients if Australia is to strike a blow against the disease when new direct-acting antivirals (DAAs) go on the PBS on March 1, activists say.

Most of Australia’s 230,000 Hep C patients have been intravenous drug users at some point, says Levinia Crooks, CEO of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).

But there may be preconceived attitudes that treatment will be a waste of money if intravenous